Can I read COVID-19: a potential driver of immune-mediated breast cancer recurrence? on EtoBox?

COVID-19: a potential driver of immune-mediated breast cancer recurrence? by Francescangeli, Federica; De Angelis, Maria Laura; Zeuner, Ann is a Medicine article available to read on EtoBox.

What is COVID-19: a potential driver of immune-mediated breast cancer recurrence? about?

## Abstract Severe coronavirus disease 2019 (COVID-19) causes a hyperactivation of immune cells, resulting in lung inflammation. Recent studies showed that COVID-19 induces the production of factors previously implicated in the reawakening of dormant breast cancer cells such as neutrophil extracellular traps (NETs). The presence of NETs and of a pro-inflammatory microenvironment may therefore promote breast cancer reactivation, increasing the risk of pulmonary metastasis. Further studies will be required to confirm the link between COVID-19 and cancer recurrence. However, an increased awareness on the potential risks for breast cancer patients with COVID-19 may lead to improved treatment strategies to prevent metastatic relapse.

Who reads COVID-19: a potential driver of immune-mediated breast cancer recurrence??

Author

Francescangeli, Federica; De Angelis, Maria Laura; Zeuner, Ann

Publisher

BioMed Central; Springer (Biomed Central Ltd.); Springer Science and Business Media LLC; Society for Mining, Metallurgy and Exploration Inc. (ISSN 1465-5411)

Published

2020

Language

EN

Field

Medicine (Health Sciences)